Further problems with thalidomide. 1989

N K James, and D J Leaper

UI MeSH Term Description Entries
D005260 Female Females
D005704 Gallbladder A storage reservoir for BILE secretion. Gallbladder allows the delivery of bile acids at a high concentration and in a controlled manner, via the CYSTIC DUCT to the DUODENUM, for degradation of dietary lipid. Gallbladders
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013792 Thalidomide A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action. Sedoval,Thalomid

Related Publications

N K James, and D J Leaper
February 1990, Journal of the Royal College of Surgeons of Edinburgh,
N K James, and D J Leaper
October 1965, Leprosy review,
N K James, and D J Leaper
January 1984, Lancet (London, England),
N K James, and D J Leaper
April 1978, Lancet (London, England),
N K James, and D J Leaper
August 1986, Clinical chemistry,
N K James, and D J Leaper
January 1992, Anaesthesia,
N K James, and D J Leaper
October 1965, Die Medizinische Welt,
N K James, and D J Leaper
January 1970, Experimentelle Pathologie,
N K James, and D J Leaper
January 1989, BMJ (Clinical research ed.),
N K James, and D J Leaper
October 1964, Revue de pathologie generale et de physiologie clinique,
Copied contents to your clipboard!